Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency

Sven W. Sauer, Jürgen G. Okun, Gert Fricker, Anne Mahringer, Ines Müller, Linda R. Crnic, Chris Mühlhausen, Georg F. Hoffmann, Friederike Hörster, Stephen I. Goodman, Cary Harding, David Koeller, Stefan Kölker

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Glutaric acid (GA) and 3-hydroxyglutaric acids (3-OH-GA) are key metabolites in glutaryl co-enzyme A dehydrogenase (GCDH) deficiency and are both considered to be potential neurotoxins. As cerebral concentrations of GA and 3-OH-GA have not yet been studied systematically, we investigated the tissue-specific distribution of these organic acids and glutarylcarnitine in brain, liver, skeletal and heart muscle of Gcdh-deficient mice as well as in hepatic Gcdh-/- mice and in C57Bl/6 mice following intraperitoneal loading. Furthermore, we determined the flux of GA and 3-OH-GA across the blood-brain barrier (BBB) using porcine brain microvessel endothelial cells. Concentrations of GA, 3-OH-GA and glutarylcarnitine were significantly elevated in all tissues of Gcdh-/- mice. Strikingly, cerebral concentrations of GA and 3-OH-GA were unexpectedly high, reaching similar concentrations as those found in liver. In contrast, cerebral concentrations of these organic acids remained low in hepatic Gcdh-/- mice and after intraperitoneal injection of GA and 3-OH-GA. These results suggest limited flux of GA and 3-OH-GA across the BBB, which was supported in cultured porcine brain capillary endothelial cells. In conclusion, we propose that an intracerebral de novo synthesis and subsequent trapping of GA and 3-OH-GA should be considered as a biochemical risk factor for neurodegeneration in GCDH deficiency.

Original languageEnglish (US)
Pages (from-to)899-910
Number of pages12
JournalJournal of Neurochemistry
Volume97
Issue number3
DOIs
StatePublished - May 2006

Fingerprint

Glutaryl-CoA Dehydrogenase
Blood-Brain Barrier
Fluxes
Brain
glutaric acid
3-hydroxyglutaric acid
Glutaric Acidemia I
Liver
Organic acids
Endothelial cells
Oxidoreductases
Swine
Endothelial Cells
Tissue

Keywords

  • Blood-brain barrier
  • Dicarboxylic acids
  • Glutaric aciduria type I
  • Neurodegeneration

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. / Sauer, Sven W.; Okun, Jürgen G.; Fricker, Gert; Mahringer, Anne; Müller, Ines; Crnic, Linda R.; Mühlhausen, Chris; Hoffmann, Georg F.; Hörster, Friederike; Goodman, Stephen I.; Harding, Cary; Koeller, David; Kölker, Stefan.

In: Journal of Neurochemistry, Vol. 97, No. 3, 05.2006, p. 899-910.

Research output: Contribution to journalArticle

Sauer, Sven W. ; Okun, Jürgen G. ; Fricker, Gert ; Mahringer, Anne ; Müller, Ines ; Crnic, Linda R. ; Mühlhausen, Chris ; Hoffmann, Georg F. ; Hörster, Friederike ; Goodman, Stephen I. ; Harding, Cary ; Koeller, David ; Kölker, Stefan. / Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. In: Journal of Neurochemistry. 2006 ; Vol. 97, No. 3. pp. 899-910.
@article{608bca190c7b44e981cd0eee236b2111,
title = "Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency",
abstract = "Glutaric acid (GA) and 3-hydroxyglutaric acids (3-OH-GA) are key metabolites in glutaryl co-enzyme A dehydrogenase (GCDH) deficiency and are both considered to be potential neurotoxins. As cerebral concentrations of GA and 3-OH-GA have not yet been studied systematically, we investigated the tissue-specific distribution of these organic acids and glutarylcarnitine in brain, liver, skeletal and heart muscle of Gcdh-deficient mice as well as in hepatic Gcdh-/- mice and in C57Bl/6 mice following intraperitoneal loading. Furthermore, we determined the flux of GA and 3-OH-GA across the blood-brain barrier (BBB) using porcine brain microvessel endothelial cells. Concentrations of GA, 3-OH-GA and glutarylcarnitine were significantly elevated in all tissues of Gcdh-/- mice. Strikingly, cerebral concentrations of GA and 3-OH-GA were unexpectedly high, reaching similar concentrations as those found in liver. In contrast, cerebral concentrations of these organic acids remained low in hepatic Gcdh-/- mice and after intraperitoneal injection of GA and 3-OH-GA. These results suggest limited flux of GA and 3-OH-GA across the BBB, which was supported in cultured porcine brain capillary endothelial cells. In conclusion, we propose that an intracerebral de novo synthesis and subsequent trapping of GA and 3-OH-GA should be considered as a biochemical risk factor for neurodegeneration in GCDH deficiency.",
keywords = "Blood-brain barrier, Dicarboxylic acids, Glutaric aciduria type I, Neurodegeneration",
author = "Sauer, {Sven W.} and Okun, {J{\"u}rgen G.} and Gert Fricker and Anne Mahringer and Ines M{\"u}ller and Crnic, {Linda R.} and Chris M{\"u}hlhausen and Hoffmann, {Georg F.} and Friederike H{\"o}rster and Goodman, {Stephen I.} and Cary Harding and David Koeller and Stefan K{\"o}lker",
year = "2006",
month = "5",
doi = "10.1111/j.1471-4159.2006.03813.x",
language = "English (US)",
volume = "97",
pages = "899--910",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency

AU - Sauer, Sven W.

AU - Okun, Jürgen G.

AU - Fricker, Gert

AU - Mahringer, Anne

AU - Müller, Ines

AU - Crnic, Linda R.

AU - Mühlhausen, Chris

AU - Hoffmann, Georg F.

AU - Hörster, Friederike

AU - Goodman, Stephen I.

AU - Harding, Cary

AU - Koeller, David

AU - Kölker, Stefan

PY - 2006/5

Y1 - 2006/5

N2 - Glutaric acid (GA) and 3-hydroxyglutaric acids (3-OH-GA) are key metabolites in glutaryl co-enzyme A dehydrogenase (GCDH) deficiency and are both considered to be potential neurotoxins. As cerebral concentrations of GA and 3-OH-GA have not yet been studied systematically, we investigated the tissue-specific distribution of these organic acids and glutarylcarnitine in brain, liver, skeletal and heart muscle of Gcdh-deficient mice as well as in hepatic Gcdh-/- mice and in C57Bl/6 mice following intraperitoneal loading. Furthermore, we determined the flux of GA and 3-OH-GA across the blood-brain barrier (BBB) using porcine brain microvessel endothelial cells. Concentrations of GA, 3-OH-GA and glutarylcarnitine were significantly elevated in all tissues of Gcdh-/- mice. Strikingly, cerebral concentrations of GA and 3-OH-GA were unexpectedly high, reaching similar concentrations as those found in liver. In contrast, cerebral concentrations of these organic acids remained low in hepatic Gcdh-/- mice and after intraperitoneal injection of GA and 3-OH-GA. These results suggest limited flux of GA and 3-OH-GA across the BBB, which was supported in cultured porcine brain capillary endothelial cells. In conclusion, we propose that an intracerebral de novo synthesis and subsequent trapping of GA and 3-OH-GA should be considered as a biochemical risk factor for neurodegeneration in GCDH deficiency.

AB - Glutaric acid (GA) and 3-hydroxyglutaric acids (3-OH-GA) are key metabolites in glutaryl co-enzyme A dehydrogenase (GCDH) deficiency and are both considered to be potential neurotoxins. As cerebral concentrations of GA and 3-OH-GA have not yet been studied systematically, we investigated the tissue-specific distribution of these organic acids and glutarylcarnitine in brain, liver, skeletal and heart muscle of Gcdh-deficient mice as well as in hepatic Gcdh-/- mice and in C57Bl/6 mice following intraperitoneal loading. Furthermore, we determined the flux of GA and 3-OH-GA across the blood-brain barrier (BBB) using porcine brain microvessel endothelial cells. Concentrations of GA, 3-OH-GA and glutarylcarnitine were significantly elevated in all tissues of Gcdh-/- mice. Strikingly, cerebral concentrations of GA and 3-OH-GA were unexpectedly high, reaching similar concentrations as those found in liver. In contrast, cerebral concentrations of these organic acids remained low in hepatic Gcdh-/- mice and after intraperitoneal injection of GA and 3-OH-GA. These results suggest limited flux of GA and 3-OH-GA across the BBB, which was supported in cultured porcine brain capillary endothelial cells. In conclusion, we propose that an intracerebral de novo synthesis and subsequent trapping of GA and 3-OH-GA should be considered as a biochemical risk factor for neurodegeneration in GCDH deficiency.

KW - Blood-brain barrier

KW - Dicarboxylic acids

KW - Glutaric aciduria type I

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=33645881325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645881325&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2006.03813.x

DO - 10.1111/j.1471-4159.2006.03813.x

M3 - Article

C2 - 16573641

AN - SCOPUS:33645881325

VL - 97

SP - 899

EP - 910

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -